USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
USANA Health Sciences Stock Up 0.9 %
USNA stock opened at $39.48 on Friday. The company’s 50-day moving average price is $43.95 and its two-hundred day moving average price is $46.15. USANA Health Sciences, Inc. has a 12 month low of $37.35 and a 12 month high of $65.27. The firm has a market cap of $752.00 million, a P/E ratio of 12.30, a P/E/G ratio of 1.28 and a beta of 0.90.
USANA Health Sciences (NYSE:USNA – Get Free Report) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. The firm had revenue of $212.87 million during the quarter, compared to the consensus estimate of $218.64 million. During the same period last year, the business earned $0.89 earnings per share. Equities analysts predict that USANA Health Sciences, Inc. will post 2.5 EPS for the current year.
Institutional Trading of USANA Health Sciences
Analysts Set New Price Targets
USNA has been the topic of a number of analyst reports. DA Davidson reduced their price target on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, July 25th. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th.
Check Out Our Latest Stock Analysis on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- What is a SEC Filing?
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
- The 3 Best Retail Stocks to Shop for in August
- Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch
- How to Invest in the Best Canadian Stocks
- Sea Limited’s E-Commerce and Fintech Strength Fuel Stock Surge
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.